MHLW Japan Proposes First Consultation Fee Increase To Compensate For Increased Consumption Tax
This article was originally published in PharmAsia News
MHLW Japan’s Central Social Insurance Medical Council proposed that the basic fee for patients’ first consultations be raised by ¥120 to ¥2,820 ($27) and the price of follow-up consultations be raised by ¥30 to ¥720 in accordance with the consumption tax hike, which comes into effect in April 2014.
You may also be interested in...
A sharp decline in the number of in-person facility inspections has forced the FDA to consider creative techniques for remotely evaluating manufacturer compliance during the COVID-19 pandemic. This and other stories topped our list of most-read Medtech Insight articles in November.
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Hikma has pushed back against a further attempt by Amarin to counter its US generic version of Vascepa, this time via a fresh lawsuit claiming that the generic induces infringement of patents protecting cardiovascular indications for which the brand is approved but which are carved out of the generic label.